1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 18 APRIL 2016

World Generic Markets 18 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - FTC Intervention Threatens Generic Marketing Exclusivity Period Value
Industry Brief - Apotex Launches Filgrastim Biosimilar
Industry Brief - Prometheus Anser IFX Test Validated For Use With Inflectra
Industry Trend Analysis - US Infliximab Approval Will Be A Boon For Pfizer And Celltrion
Industry Brief - Mylan Launches Lamivudine Tablets
Industry Trend Analysis - Wider Drug Pricing Issue Lies Behind MedPAC Recommendations
Industry Brief - Lupin Launches Zolpidem Sublingual Tablets
Industry Brief - FDA Accepts Hikma's Fluticasone+Salmeterol ANDA For Filing
Industry Brief - Aurobindo Gains Polymyxin B Approval
Industry Brief - Mylan Launches Intermediate Metoprolol Tartate Dosages
Industry Brief - Impax Launches Mebendazole Chewable Tablets
Industry Trend Analysis - OGD Annual Report Issued With An Eye To GDUFA Reauthorisation
Industry Brief - Promius Pharma Launches Sumatriptan Product
Industry Brief - Sandoz Gains EC Epoetin Alfa Extension Approval
Industry Brief - Samsung Bioepis Infliximab Gains Positive CHMP Opinion
Industry Trend Analysis - EU Glatiramer Approval Positions Synthon To Compete With Sandoz
Industry Brief - Martindale Pharma Launches Phenylephrine In UK
Industry Trend Analysis - UK Biosimilar Market Gaining Traction
Industry Brief - Yabao And Salus Enter Generic Drug Partnership
Industry Trend Analysis - EU-India Summit Highlights Intellectual Property Concerns
Industry Brief - Chugai Gains Japanese Maxacalcitol Patent Battle Win
Industry Trend Analysis - DNDi HCV Programme Heralds New Access To Medicines Paradigm

Table Of Contents

World Generic Markets 18 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.